Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- ARIAD Pharmaceuticals Inc. Q4 2008 Earnings Call Transcript
- Question-and-Answer SessionOperator Operator Instructions Your first question comes from the line of Jim Birchenough from Barclays Capital. Please proceed sir. Ryan Martins - Barclays Capital Hi, actually this is Ryan Martins in for Jim Birchenough, thanks for taking my call. I was wondering if you guys could give...
- Earnings calls 2009-02-12
Additional Resources
- Life Extension Foundation sponsors highly promising breast cancer trial
- According to the National Cancer Institute, more than 40,000 women will die of breast cancer this year, while nearly 180,000 new cases of the dread disease will be diagnosed. (1) Over the course of a lifetime, one in eight women will receive such a diagnosis. (2) Breast cancer is an...
- Research articles 2007-08-01
- Celsion to Proceed with Phase II Pivotal Breast Cancer Trial after Receiving Supportive FDA Response
- Expects to Initiate Trial in Ten US Centers COLUMBIA, Md. -- CELSION CORPORATION (AMEX: CLN) today announced that it had received a supportive written response from the FDA in relation to its proposed registrational study for use of ThermoDox in patients with recurrent breast cancer at the chest wall....
- Research articles 2008-01-15
- Wyeth Loses Prempro Trial Over Breast Cancer Link
- A Philadelphia jury returned a sealed punitive-damages verdict late yesterday against the drug maker after finding a link between a woman's breast cancer and the hormone-replacement drug, the Associated Press reports. Connie Barton's case is one of a handful of Prempro lawsuits to go to trial out of several thousand...
- News items 2009-10-27
- U.S. HHS: Breast cancer prevention trial results published.
- M2 PRESSWIRE-17 September 1998-U.S. HHS: Breast cancer prevention trial results published C1994-98 M2 COMMUNICATIONS LTD RDATE:140998 Researchers from the Breast Cancer Prevention Trial BCPT have published a full report and update of the study in the September 16, 1998, Journal of...
- Research articles 1998-09-17
- First Patients Enrolled in Three Breast Cancer Studies for Bioenvision's Modrenal®
- NEW YORK -- Bioenvision (Nasdaq:BIVN) today announced that the first patients have been enrolled and commenced treatment in three separate, clinical studies of ModrenalR trilostane. These studies are investigating the efficacy of Modrenal in three distinct settings: (1) a Phase IV trial in advanced, post-menopausal breast cancer, (2) a Phase...
- Research articles 2005-11-17
- Martin Memorial to Participate in International Clinical Trial for Breast Cancer sponsored by ART
- The Robert and Carol Weissman Cancer Center at Martin Memorial will be one of eight facilities in the U.S. and Canada to test SoftScan, a new diagnostic technology developed by ART Advanced Research Technologies (TSX:ARA) The Robert and Carol Weissman Cancer Center at Martin Memorial is taking part in...
- Research articles 2006-04-24
- Immunicon Corporation to Conduct Circulating Tumor Cell Testing for Breast Cancer Clinical Trial Conducted by the Southwest Oncology Group
- HUNTINGDON VALLEY, Pa. -- Immunicon Corporation (NASDAQ-GM:IMMC) announced today that a major clinical trial conducted by the Southwest Oncology Group SWOG has opened to enrollment. The trial is a randomized Phase III trial designed to determine whether changing cancer therapy when circulating tumor cells CTCs are elevated at the first...
- Research articles 2006-11-28
- Pfizer Loses Two HRT Suits Over Breast Cancer
- The drugmaker was ordered to pay a total of $103 million in punitive damages to two women who were found to have breast cancer after they used the Prempro or Premarin hormone replacement therapies. In one case, a jury awarded $28 million and a judge unsealed another case from last...
- News items 2009-11-24
- Tamoxifen trial resumes - National Surgical Adjuvant Breast and Bowel's Breast Cancer Prevention Trail - Brief Article
- On Nov.9, the University of Pittsburgh resumed its enrollment of healthy women into the Breast Cancer Prevention Trial--the first of some 300 participating centers to do so. Directed by the National Surgical Adjuvant Breast and Bowel Project NSABP, this study began in early 1992. But recruitment of new volunteers to...
- Research articles 1994-11-19
- FDA Advisory Panel Recommends Approval of Zeneca's Nolvadex -Tamoxifen Citrate- for Reduction of Incidence of Breast Cancer in Women At Increased Risk
- WILMINGTON, Del.--BUSINESS WIRE--Sept. 2, 1998--Zeneca Pharmaceuticals said that it is encouraged by today's decision by the U.S. Food and Drug Administration's FDA Oncologic Drugs Advisory Committee ODAC to recommend for approval NOLVADEXR tamoxifen citrate for reduction of the incidence of breast cancer in women at increased risk, as defined by...
- Research articles 1998-09-02
- FDA Advisory Panel Recommends Approval of Zeneca's Nolvadex -Tamoxifen Citrate- for Reduction of Incidence of Breast Cancer in Women At Increased Risk
- WILMINGTON, Del.--BUSINESS WIRE--Sept. 2, 1998--Zeneca Pharmaceuticals said that it is encouraged by today's decision by the U.S. Food and Drug Administration's FDA Oncologic Drugs Advisory Committee ODAC to recommend for approval NOLVADEXR tamoxifen citrate for reduction of the incidence of breast cancer in women at increased risk, as defined by...
- Research articles 1998-09-02
- Sonus Pharmaceuticals to Present TOCOSOL® Paclitaxel Clinical Data in Metastatic Breast Cancer at San Antonio Breast Cancer Symposium
- SEATTLE -- Sonus Pharmaceuticals, Inc. (NASDAQ:SNUS) today announced the scheduled presentation of a poster on TOCOSOLR Paclitaxel at the upcoming San Antonio Breast Cancer Symposium, to be held in San Antonio, Texas from December 8-11. The poster presentation will include efficacy data from an ongoing Phase 2 trial in metastatic...
- Research articles 2005-12-02
- Allstate Workplace Division Sponsors Clinical Trial for Breast Cancer Vaccine
- JACKSONVILLE, Fla. -- Allstate Workplace Division, a subsidiary of The Allstate Corporation, has funded a grant for $220,426 through Gateway for Cancer Research formerly known as Cancer Treatment Research Foundation to support a Phase I Clinical Trial of a vaccine that may fight Stage IV breast cancer.
- Research articles 2007-07-25
- Martin Memorial to Participate in International Clinical Trial for Breast Cancer sponsored by ART.
- STUART, FLORIDA, Apr 24, 2006 CCNMatthews via COMTEX -- The Robert and Carol Weissman Cancer Center at Martin Memorial will be one of eight facilities in the U.S. and Canada to test SoftScan, a new diagnostic technology developed by ART Advanced Research Technologies (TSX:ARA) ...
- Research articles 2006-04-24
- Updated Data from Investigator-sponsored Phase I Trial of NeoRx's STR in Breast Cancer Patients Presented at the 2005 Tandem BMT Meetings
- SEATTLE -- NeoRx Corporation (NASDAQ:NERX) today announced the presentation of updated data from an investigator-sponsored Phase I Trial of STRTM, NeoRx's investigational bone-targeted radiotherapeutic, in patients with advanced breast cancer. The data were presented by Richard Champlin, M.D., chair of the Department of Blood and Marrow Transplantation at MD Anderson...
- Research articles 2005-02-14
- FDA Approves Phase I Clinical Trial for SKCC Breast Cancer Vaccine
- SAN DIEGO -- The Federal Drug Administration announced Friday approval of a Phase 1 clinical trial designed to study a breast cancer vaccine developed at the Sidney Kimmel Cancer Center (http://www.skcc.org).
- Research articles 2007-12-10
- Sonus Pharmaceuticals Announces Completion of Patient Enrollment in Phase 3 Pivotal Trial of TOCOSOL® Paclitaxel in Metastatic Breast Cancer
- BOTHELL, Wash. -- Sonus Pharmaceuticals, Inc. (NASDAQ: SNUS) today announced that it has completed enrollment in the Phase 3 pivotal trial of its lead oncology product candidate, TOCOSOL([R])Paclitaxel, in women with metastatic breast cancer. Formulated with the Company's proprietary vitamin E-based emulsion TOCOSOL technology, TOCOSOL Paclitaxel is a new formulation...
- Research articles 2006-11-16
- The Vital First Years in Breast Cancer Care: New Data Confirm That Using 'Arimidex' (anastrozole) From the Start Can Help More Women Live Cancer-Free for Longer.
- MACCLESFIELD, England, May 16 /PRNewswire/ -- Today, the crucial benefits of using 'Arimidex' anastrozole to help postmenopausal women continue to live free from breast cancer, were confirmed by the latest data from the groundbreaking ATAC* trial(1), presented at the American Society of...
- Research articles 2005-05-16
- Sonus Pharmaceuticals Initiates Pivotal Phase 3 Trial of TOCOSOL® Paclitaxel for Treatment of Metastatic Breast Cancer
- BOTHELL, Wash. -- Sonus Pharmaceuticals, Inc. (NASDAQ:SNUS) today announced the initiation of the pivotal Phase 3 trial of TOCOSOLR Paclitaxel that is intended to serve as the basis for approval of the product by the U.S. Food and Drug Administration FDA. The two-arm, randomized study is being conducted under a...
- Research articles 2005-09-28
- << Previous
- page 1 of 1
- Next >>
Presented by American Express